Profile
Consonance Capital Partners is a private equity firm based in New York, specializing in healthcare investments. Founded in 2005 by Mitchell Blutt, MD, along with Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, the firm focuses on partnering with management teams that drive sustainable value in the healthcare system. The firm's team of seasoned professionals has extensive experience primarily gained from their tenures at J.P. Morgan Partners. Consonance is distinguished by its emphasis on efficiency, cost containment, and quality care in healthcare businesses across the United States.
Consonance Capital Partners targets lower- to middle-market healthcare companies, offering investment in growth equity, leveraged buyouts, recapitalizations, and special situations. Geared towards improving operational efficiency and patient care quality, Consonance has launched several funds, including Consonance Private Equity I and II, before reaching the hard cap with its third fund at $1.35 billion. The firm's diverse investor base includes endowments, foundations, pension plans, financial institutions, and other institutional investors worldwide.
Notable portfolio companies include companies that enhance supply chain efficiency and patient care solutions. The firm's strategic focus in healthcare investments helps it maintain strong collaborations with high-caliber management teams, reinforcing its commitment to high-quality, cost-effective healthcare delivery.
Industry
Consonance Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Consonance Private Equity III
|
Private Equity (PE)
|
Healthcare Services
|
Late Stage (Series C+)
|
North America
|
$100+ m
|
—
|
October 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.